drugset / Trial / NCT06023420

Efficacy of a Herbal Formula for Bone Metastases

NCT06023420

Phase 1/2 Unknown 36 enrolled Chinese University of Hong Kong
RandomizedParallel-groupOpen-labelSupportive care

Summary

RATIONALE: Nearly 50% of patients with bone metastases develop one or more complications collectively termed skeletal-related events (SREs). The study herbal medicine might reduce the morbidities due to "Skeletal-related events" (SRES), and extend survival time. PURPOSE: the study is to explore the effects of the 4 Herbs Formula on the reduction of "Skeletal-related events" (SRES), and survival time.

Timeline

Start
2024-02-01
Primary completion
2024-12-31
Completion
2025-01-01

Drugs

EvaluationDrugModalityDoseRoute
Background Zoledronic acid Other / unclassified 5 g
Background Zoledronic acid Other / unclassified

Indications